By addressing regional data gaps and leveraging the IGRA’s diagnostic precision, this study aimed to determine LTBI prevalence using interferon-gamma release assays (IGRAs) and identify associated risk factors in IMID patients in a middle-high TB burden setting in Mexico. The gene discussed is IFNG; the disease is tuberculosis.